What question did this study set out to answer?

This research aims to explore the effects of bacillus amyloliquefaciens TL106 on metabolic health and gut microbiota in sows and piglets.

March 3, 2026Open Access

Probiotic efficacy of Bacillus amyloliquefaciens TL106 from Tibetan pigs in metabolic syndrome: modulation of gut microbiota and metabolic in sows and suckling piglets

Key Points

This research aims to explore the effects of bacillus amyloliquefaciens TL106 on metabolic health and gut microbiota in sows and piglets.
Evaluated bacillus amyloliquefaciens TL106 in Landrace × Yorkshire sows.
Assessed effects on metabolic syndrome and gut microbiota.
Studied neonatal development in Duroc × Landrace × Yorkshire suckling piglets.
Enhanced maternal metabolic health observed.
Improvement in neonatal development noted.
Significant reshaping of gut microbiota reported.

Abstract

Bacillus amyloliquefaciens TL106 simultaneously enhanced maternal metabolic health and neonatal development by reshaping gut microbiota and host metabolism, positioning it as a micro‑ecological tool for managing metabolic syndrome in Landrace × Yorkshire sows and Duroc × Landrace × Yorkshire suckling piglets. Video Abstract.

Bookmark

View Full Paper

Bookmark

View Full Paper

Probiotic efficacy of Bacillus amyloliquefaciens TL106 from Tibetan pigs in metabolic syndrome: modulation of gut microbiota and metabolic in sows and suckling piglets

Key Points

Abstract

Cite This Study